Just to add what many don't realize is that Biosante still has global rights to Bio-t-gel and Elestrin outside of the US. Smart move on their part, let the market for these products develop once they are popular they can obtain a greater royalty percentage for the rest of the world. Or use the money from royalties to help launch their global marketing efforts.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.